Owners, management and financials
CVR: 56750215
Previous names: HANS LUNDBECK A/S
DKK 18,887,000
Revenue
Net result: DKK 2,291,000
H. LUNDBECK A/S (100%)
CVR · view owners
Søren Klein-Kristensen
Board: Michala Fischer-Hansen (chair) and 2 members
CVR · view management
Active
Founded 24 February 1958
CVR · view overview
17 employees
CVR · 2018
Director registered: Søren Klein-Kristensen
CVR · 01/07/2026
View the full event history
LUNDBECK PHARMA A/S is a Danish company of the type Aktieselskab based in Valby, founded in 1958. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANS LUNDBECK A/S. The management consists of Søren Klein-Kristensen. The board consists of Michala Fischer-Hansen (chair), Søren Klein-Kristensen and Thomas Bo Bjørn Klee. The company is owned by H. LUNDBECK A/S. The company has 17 employees (2018). In 2025, the company reported revenue of DKK 18,887,000 and a net result of DKK 2,291,000 compared with DKK 1,820,000 the year before. Equity in the 2025 report amounted to DKK 3,378,000.
Source: annual report 2025, Danish Business Authority
Lundbeck Pharma A/S demonstrates a positive financial trajectory, with revenue increasing from 15,968,000 DKK in 2023 to 18,887,000 DKK in 2025, reflecting a steady growth trend. Profitability has also improved, rising from 991,000 DKK in 2023 to 2,291,000 DKK in 2025, indicating enhanced operational efficiency and margins. However, equity has slightly declined from 3,484,000 DKK in 2024 to 3,378,000 DKK in 2025, which may raise concerns regarding financial stability. Positioned within the pharmaceutical wholesale industry, Lundbeck Pharma's growth and profitability suggest a solid standing, though ongoing monitoring of equity and market conditions is advisable.
AI-generated summary · Generated 20/03/2026
Selskabets formål er at drive handelsvirksomhed med human medicin samt, efter bestyrlsens skøn, anden i forbindelse dermed stående virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 18.9 mio. | 2.3 mio. | 19.5 mio. | 3.4 mio. | 18 | |
| 202401/01/2024 – 31/12/2024 | 18.3 mio. | 1.8 mio. | 19.6 mio. | 3.5 mio. | 20 | |
| 202301/01/2023 – 31/12/2023 | 16 mio. | 991 t. | 16.7 mio. | 2.5 mio. | - | |
| 202201/01/2022 – 31/12/2022 | 17 mio. | 982 t. | 12.6 mio. | 2.3 mio. | - | |
| 202101/01/2021 – 31/12/2021 | 16.5 mio. | 1.2 mio. | 16 mio. | 2.4 mio. | 20 | |
| 202001/01/2020 – 31/12/2020 | 19.2 mio. | -5.1 mio. | 14.1 mio. | -1.6 mio. | 20 | |
| 201901/01/2019 – 31/12/2019 | 17.3 mio. | 497 t. | 14 mio. | 3.7 mio. | 18 | |
| 201801/01/2018 – 31/12/2018 | 18.4 mio. | 736 t. | 12.4 mio. | 3.8 mio. | 18 | |
| 201701/01/2017 – 31/12/2017 | 19.7 mio. | 365 t. | 16.4 mio. | 3.3 mio. | 14 | |
| 201601/01/2016 – 31/12/2016 | 20.8 mio. | 48 t. | 9.4 mio. | 3 mio. | 8 | |
| 201501/01/2015 – 31/12/2015 | 27 mio. | -129 t. | 25.7 mio. | 3 mio. | - | |
| 201401/01/2014 – 31/12/2014 | 27.7 mio. | 184 t. | 36 mio. | 3.1 mio. | - | |
| 201301/01/2013 – 31/12/2013 | 33 mio. | -89 t. | 24.1 mio. | 3 mio. | - | |
| 201201/01/2012 – 31/12/2012 | 43.8 mio. | 691 t. | 12.1 mio. | 3 mio. | - |
Compared to 406 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
2 public tenders won
Sources: TED (the EU tender database) and udbud.dk
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorThe CVR number of LUNDBECK PHARMA A/S is 56750215.
LUNDBECK PHARMA A/S is owned by H. LUNDBECK A/S.
The management of LUNDBECK PHARMA A/S consists of Søren Klein-Kristensen.
The board of LUNDBECK PHARMA A/S consists of Michala Fischer-Hansen, Søren Klein-Kristensen and Thomas Bo Bjørn Klee, with Michala Fischer-Hansen as chair.
In 2025, LUNDBECK PHARMA A/S reported revenue of DKK 18,887,000.
LUNDBECK PHARMA A/S had 17 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 43714270 (July 2, 2026).
Contact info changed: new phone: 43714270 (July 1, 2026).
As of July 1, 2026, Thomas Bo Bjørn Klee has joined the board of directors of LUNDBECK PHARMA A/S.
As of July 1, 2026, Johannes Michael Leuchs has left the board of directors of LUNDBECK PHARMA A/S.
As of July 1, 2026, Søren Klein-Kristensen is registered as adm. dir. of LUNDBECK PHARMA A/S.
As of July 1, 2026, Johannes Michael Leuchs has stepped down as adm. dir. of LUNDBECK PHARMA A/S.
LUNDBECK PHARMA A/S has published its annual report for 2025. Revenue came to DKK 18,887,000, and the net result was DKK 2,291,000.
LUNDBECK PHARMA A/S has won the tender "Amgros 2026 1.1060.a" issued by Amgros I/S worth 1,288,800,000 DKK.
As of April 1, 2025, Johannes Michael Leuchs has joined the board of directors of LUNDBECK PHARMA A/S.
As of April 1, 2025, Thomas Bo Bjørn Klee has left the board of directors of LUNDBECK PHARMA A/S.
As of April 1, 2025, Johannes Michael Leuchs is registered as adm. dir. of LUNDBECK PHARMA A/S.
As of April 1, 2025, Thomas Bo Bjørn Klee has stepped down as adm. dir. of LUNDBECK PHARMA A/S.
LUNDBECK PHARMA A/S has published its annual report for 2024. Revenue came to DKK 18,343,000, and the net result was DKK 1,820,000.
As of September 16, 2024, Søren Klein-Kristensen has joined the board of directors of LUNDBECK PHARMA A/S.
As of September 16, 2024, Dierk Erwin Schoch has left the board of directors of LUNDBECK PHARMA A/S.
LUNDBECK PHARMA A/S has won the tender "Amgros 2024 1.1060.a" issued by Amgros I/S worth 686,000,000 DKK.
As of April 2, 2024, Michala Fischer-Hansen has joined the board of directors of LUNDBECK PHARMA A/S.
As of April 2, 2024, Ole Wendler Pedersen has left the board of directors of LUNDBECK PHARMA A/S.
LUNDBECK PHARMA A/S has published its annual report for 2023. Revenue came to DKK 15,968,000, and the net result was DKK 991,000.
As of February 26, 2024, Ole Wendler Pedersen has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 26, 2024, Jacob Tolstrup has left the board of directors of LUNDBECK PHARMA A/S.
LUNDBECK PHARMA A/S has published its annual report for 2022. Revenue came to DKK 16,955,000, and the net result was DKK 982,000.
LUNDBECK PHARMA A/S has published its annual report for 2021. Revenue came to DKK 16,497,000, and the net result was DKK 1,242,000.
LUNDBECK PHARMA A/S has published its annual report for 2020. Revenue came to DKK 19,163,000, and the net result was DKK -5,144,000.
As of March 19, 2020, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of LUNDBECK PHARMA A/S.
As of March 19, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of LUNDBECK PHARMA A/S.
As of January 1, 2020, Dierk Erwin Schoch has joined the board of directors of LUNDBECK PHARMA A/S.
As of January 1, 2020, Joao Carlos Nunes Rocha has left the board of directors of LUNDBECK PHARMA A/S.
As of July 1, 2019, Thomas Bo Bjørn Klee has joined the board of directors of LUNDBECK PHARMA A/S.
As of July 1, 2019, Christoffer Dahl has left the board of directors of LUNDBECK PHARMA A/S.
As of July 1, 2019, Thomas Bo Bjørn Klee is registered as adm. dir. of LUNDBECK PHARMA A/S.
As of July 1, 2019, Christoffer Dahl has stepped down as director of LUNDBECK PHARMA A/S.
LUNDBECK PHARMA A/S has published its annual report for 2018. Revenue came to DKK 18,357,000, and the net result was DKK 736,000.
LUNDBECK PHARMA A/S has published its annual report for 2017. Revenue came to DKK 19,675,000, and the net result was DKK 365,000.
As of November 14, 2017, Jacob Tolstrup has joined the board of directors of LUNDBECK PHARMA A/S.
As of November 14, 2017, Staffan Schüberg has left the board of directors of LUNDBECK PHARMA A/S.
LUNDBECK PHARMA A/S has published its annual report for 2016. Revenue came to DKK 20,834,000, and the net result was DKK 48,000.
As of December 12, 2016, Joao Carlos Nunes Rocha has joined the board of directors of LUNDBECK PHARMA A/S.
As of December 12, 2016, Staffan Schüberg has joined the board of directors of LUNDBECK PHARMA A/S.
As of December 12, 2016, Adrianus Marinus van der Vliet has left the board of directors of LUNDBECK PHARMA A/S.
As of December 12, 2016, Christoffer Dahl is registered as director of LUNDBECK PHARMA A/S.
As of December 12, 2016, Adrianus Marinus van der Vliet has stepped down as adm. dir. of LUNDBECK PHARMA A/S.
As of December 11, 2016, Joao Carlos Nunes Rocha has left the board of directors of LUNDBECK PHARMA A/S.
LUNDBECK PHARMA A/S has published its annual report for 2015. Revenue came to DKK 27,047,000, and the net result was DKK -129,000.
As of December 1, 2015, Christoffer Dahl has joined the board of directors of LUNDBECK PHARMA A/S.
As of December 1, 2015, Thomas Bo Bjørn Klee has left the board of directors of LUNDBECK PHARMA A/S.
LUNDBECK PHARMA A/S has published its annual report for 2014. Revenue came to DKK 27,725,000, and the net result was DKK 184,000.
LUNDBECK PHARMA A/S has published its annual report for 2013. Revenue came to DKK 33,008,000, and the net result was DKK -89,000.
As of January 15, 2014, Adrianus Marinus van der Vliet is registered as adm. dir. of LUNDBECK PHARMA A/S.
As of January 15, 2014, Thomas Bo Bjørn Klee has stepped down as adm. dir. of LUNDBECK PHARMA A/S.
As of January 14, 2014, Thomas Bo Bjørn Klee has joined the board of directors of LUNDBECK PHARMA A/S.
As of January 14, 2014, Joao Carlos Nunes Rocha has joined the board of directors of LUNDBECK PHARMA A/S.
As of January 14, 2014, Adrianus Marinus van der Vliet has joined the board of directors of LUNDBECK PHARMA A/S.
LUNDBECK PHARMA A/S has published its annual report for 2012. Revenue came to DKK 43,784,000, and the net result was DKK 691,000.
As of January 14, 2013, Ole Chrintz has left the board of directors of LUNDBECK PHARMA A/S.
As of January 14, 2013, Michael Quiqueran-Beaujeu has left the board of directors of LUNDBECK PHARMA A/S.
As of January 14, 2013, Leif-Petter Jokinen has left the board of directors of LUNDBECK PHARMA A/S.
As of December 1, 2012, Thomas Bo Bjørn Klee is registered as adm. dir. of LUNDBECK PHARMA A/S.
As of November 30, 2012, Jan Hasseriis Iversen has stepped down as adm. dir. of LUNDBECK PHARMA A/S.
As of November 1, 2012, Ole Chrintz has joined the board of directors of LUNDBECK PHARMA A/S.
As of November 1, 2012, Cornelia Brigitte Bolz has joined the board of directors of LUNDBECK PHARMA A/S.
As of November 1, 2012, Michael Quiqueran-Beaujeu has joined the board of directors of LUNDBECK PHARMA A/S.
As of November 1, 2012, Leif-Petter Jokinen has joined the board of directors of LUNDBECK PHARMA A/S.
As of November 1, 2012, Stig Løkke Pedersen has left the board of directors of LUNDBECK PHARMA A/S.
As of November 1, 2012, Erik Allikmets has left the board of directors of LUNDBECK PHARMA A/S.
As of November 1, 2012, Staffan Schüberg has left the board of directors of LUNDBECK PHARMA A/S.
As of November 1, 2012, Cornelia Brigitte Bolz has left the board of directors of LUNDBECK PHARMA A/S.
As of October 13, 2011, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of LUNDBECK PHARMA A/S.
As of October 13, 2011, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of LUNDBECK PHARMA A/S.
As of October 15, 2008, Stig Løkke Pedersen has joined the board of directors of LUNDBECK PHARMA A/S.
As of October 15, 2008, Erik Allikmets has joined the board of directors of LUNDBECK PHARMA A/S.
As of October 26, 2005, Ole Chrintz has left the board of directors of LUNDBECK PHARMA A/S.
As of October 1, 2005, Staffan Schüberg has joined the board of directors of LUNDBECK PHARMA A/S.
As of October 1, 2005, Marianne Vinther has left the board of directors of LUNDBECK PHARMA A/S.
As of February 16, 2004, Marianne Vinther has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 16, 2004, Ole Chrintz has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 16, 2004, Jens Gaardbo has left the board of directors of LUNDBECK PHARMA A/S.
As of February 16, 2004, Erik Sprunk-Jansen has left the board of directors of LUNDBECK PHARMA A/S.
As of February 16, 2004, Lars Bang has left the board of directors of LUNDBECK PHARMA A/S.
As of February 16, 2004, Jarl Håkan Kotka has left the board of directors of LUNDBECK PHARMA A/S.
As of January 1, 2003, Jens Gaardbo has joined the board of directors of LUNDBECK PHARMA A/S.
As of January 1, 2003, Harald Conradi-Larsen has left the board of directors of LUNDBECK PHARMA A/S.
As of January 1, 2003, Hans Henrik Munch-Jensen has left the board of directors of LUNDBECK PHARMA A/S.
As of May 10, 2001, Jarl Håkan Kotka has joined the board of directors of LUNDBECK PHARMA A/S.
As of May 10, 2001, Stig Eilert Paulsen has left the board of directors of LUNDBECK PHARMA A/S.
As of November 1, 2000, Lars Bang has joined the board of directors of LUNDBECK PHARMA A/S.
As of November 1, 2000, Stig Eilert Paulsen has joined the board of directors of LUNDBECK PHARMA A/S.
As of November 1, 2000, Flemming Juul Jensen has left the board of directors of LUNDBECK PHARMA A/S.
As of November 1, 2000, Rolf Gunnar Gisel-Ekdahl has left the board of directors of LUNDBECK PHARMA A/S.
As of October 27, 1999, Hans Henrik Munch-Jensen has joined the board of directors of LUNDBECK PHARMA A/S.
As of October 27, 1999, Søren Hjuler Vogelsang has left the board of directors of LUNDBECK PHARMA A/S.
As of February 24, 1999, Harald Conradi-Larsen has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 24, 1999, Ole Steen Antonsen has left the board of directors of LUNDBECK PHARMA A/S.
As of August 18, 1998, Flemming Juul Jensen has joined the board of directors of LUNDBECK PHARMA A/S.
As of January 1, 1998, Rolf Gunnar Gisel-Ekdahl has joined the board of directors of LUNDBECK PHARMA A/S.
As of December 31, 1997, Harald Conradi-Larsen has left the board of directors of LUNDBECK PHARMA A/S.
As of May 7, 1997, Eva Steiness has left the board of directors of LUNDBECK PHARMA A/S.
As of May 30, 1996, H. LUNDBECK A/S is registered as an owner of LUNDBECK PHARMA A/S with an ownership share of 100%.
As of January 16, 1996, Erik Sprunk-Jansen has joined the board of directors of LUNDBECK PHARMA A/S.
As of January 16, 1996, Eva Steiness has joined the board of directors of LUNDBECK PHARMA A/S.
As of January 1, 1996, Søren Hjuler Vogelsang has joined the board of directors of LUNDBECK PHARMA A/S.
As of January 1, 1996, Ib Dybdahl Christoffersen has left the board of directors of LUNDBECK PHARMA A/S.
As of November 24, 1995, Kurt Kruhøffer has left the board of directors of LUNDBECK PHARMA A/S.
As of July 13, 1995, Harald Conradi-Larsen has joined the board of directors of LUNDBECK PHARMA A/S.
As of July 13, 1995, Ole Steen Antonsen has joined the board of directors of LUNDBECK PHARMA A/S.
As of July 13, 1995, Rolf Gunnar Gisel-Ekdahl has left the board of directors of LUNDBECK PHARMA A/S.
As of July 13, 1995, Jan Hasseriis Iversen is registered as adm. dir. of LUNDBECK PHARMA A/S.
As of July 13, 1995, Harald Conradi-Larsen has stepped down as director of LUNDBECK PHARMA A/S.
As of May 17, 1995, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of LUNDBECK PHARMA A/S.
As of May 17, 1995, Søren Bjerre-Nielsen has stepped down as auditor of LUNDBECK PHARMA A/S.
As of April 27, 1995, Søren Hjuler Vogelsang has left the board of directors of LUNDBECK PHARMA A/S.
As of April 1, 1995, Carl-Emil Ramm Sandberg has left the board of directors of LUNDBECK PHARMA A/S.
As of April 1, 1995, Erik Sprunk-Jansen has left the board of directors of LUNDBECK PHARMA A/S.
As of January 30, 1995, Flemming Juul Jensen has left the board of directors of LUNDBECK PHARMA A/S.
As of January 30, 1995, Rolf Gunnar Gisel-Ekdahl has stepped down as director of LUNDBECK PHARMA A/S.
As of June 9, 1994, Flemming Juul Jensen has stepped down as director of LUNDBECK PHARMA A/S.
As of February 15, 1993, Eva Steiness has left the board of directors of LUNDBECK PHARMA A/S.
As of April 9, 1992, Mogens Franck Gustav Ekström has left the board of directors of LUNDBECK PHARMA A/S.
As of June 18, 1991, Haldor Christensen has left the board of directors of LUNDBECK PHARMA A/S.
As of May 26, 1989, Olaf Thrane has left the board of directors of LUNDBECK PHARMA A/S.
As of November 30, 1988, Anne-Grethe Laursen has left the board of directors of LUNDBECK PHARMA A/S.
As of October 3, 1988, Martin Vilhelm Lind has stepped down as auditor of LUNDBECK PHARMA A/S.
On November 6, 1987, the company changed its name from HANS LUNDBECK A/S to LUNDBECK PHARMA A/S.
As of November 5, 1987, Arne Villy Jensen has left the board of directors of LUNDBECK PHARMA A/S.
As of November 5, 1987, H. LUNDBECK A/S has stepped down as director of LUNDBECK PHARMA A/S.
As of February 24, 1958, Martin Vilhelm Lind has been appointed auditor of LUNDBECK PHARMA A/S.
As of February 24, 1958, Søren Bjerre-Nielsen has been appointed auditor of LUNDBECK PHARMA A/S.
As of February 24, 1958, Carl-Emil Ramm Sandberg has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 24, 1958, Mogens Franck Gustav Ekström has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 24, 1958, Flemming Juul Jensen has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 24, 1958, Ib Dybdahl Christoffersen has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 24, 1958, Erik Sprunk-Jansen has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 24, 1958, Arne Villy Jensen has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 24, 1958, Haldor Christensen has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 24, 1958, Søren Hjuler Vogelsang has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 24, 1958, Olaf Thrane has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 24, 1958, Kurt Kruhøffer has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 24, 1958, Anne-Grethe Laursen has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 24, 1958, Eva Steiness has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 24, 1958, Rolf Gunnar Gisel-Ekdahl has joined the board of directors of LUNDBECK PHARMA A/S.
As of February 24, 1958, Flemming Juul Jensen is registered as director of LUNDBECK PHARMA A/S.
As of February 24, 1958, Harald Conradi-Larsen is registered as director of LUNDBECK PHARMA A/S.
As of February 24, 1958, H. LUNDBECK A/S is registered as director of LUNDBECK PHARMA A/S.
As of February 24, 1958, Rolf Gunnar Gisel-Ekdahl is registered as director of LUNDBECK PHARMA A/S.
LUNDBECK PHARMA A/S was founded on February 24, 1958.
Companies in the same industry and area
CVR 43707795
CVR 35818790
CVR 39791447
CVR 40051481
CVR 33597037
